can glp 1 cause late period Your guide to GLP-1 side effects glp 1 missed period Glucagon-like

2021;11:e047993

Preclinical trials and clinical assessments of the drug have produced remarkable results, prompting the United States Food and Drug Administration (FDA) to approve its use as a first-in-class medicine in May 2022

Butler JM, Guthrie SM, Koc M, Afzal A, Caballero S, Brooks HL, Mames RN, Segal MS, Grant MB, Scott EW

Unauthorized or counterfeit injectable products carry even more risks, such as infections due to lack of sterility, allergic reactions and other serious negative outcomes due to contamination, improper handling or unsafe administration, Health Canada said

Romero-Gmez M, Lawitz E, Shankar RR, Chaudhri E, Liu J, Lam RLH, Kaufman KD, Engel SS, Group (2023) A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with nonalcoholic fatty liver disease